Literature DB >> 25120765

Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.

Lin Zhang1, Shu-Biao Ye2, Ze-Lei Li2, Gang Ma3, Shi-Ping Chen4, Jia He2, Wan-Li Liu1, Dan Xie5, Yi-Xin Zeng5, Jiang Li2.   

Abstract

The expression of hypoxia-induced factor (HIF)-1α is up-regulated in tumor microenvironments under hypoxia condition. However, the prognostic significance of HIF-1α in esophageal squamous cell carcinoma (ESCC) is still elusive. We measured the HIF-1α expression by immunochemistry in tumor specimens from 136 resected ESCC; in the current study, the HIF-1α expression in tumor cells was significantly associated with tumor stage (P = 0.003) and lymph node metastasis (P = 0.006); whereas the HIF-1α expression in tumor-infiltrating lymphocytes (TILs) had no relationship with patients' clinicopathological parameters. Patients with high HIF-1α expression in tumor cells or in TILs showed worse survival related to those with low HIF-1α expression. Multivariate analysis demonstrated that expression of HIF-1α in TILs was an independent factor for DFS (P = 0.007) and OS (P = 0.013). Additionally, the expression of HIF-1α in tumor cells was an independent factor for DFS (P = 0.037) and OS (P = 0.033) in locoregional ESCC patients, whereas the expression of HIF-1α in TILs was an independent factor for DFS (P = 0.048) and OS (P = 0.039) in metastatic ESCC patients. Correlation analysis revealed that expressions of HIF-1α in tumor cells and in TILs were positively correlated, and patients with combined high HIF-1α in both tumor cells and TILs had the worst survivals (P < 0.05). These findings suggest that the HIF-1α expressions in different cell populations of ESCC microenvironments have different clinical relevance and prognostic impact on patients.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; HIF-1α; clinical prognosis; tumor microenvironments; tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2014        PMID: 25120765      PMCID: PMC4129000     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.

Authors:  Li-Ru He; Meng-Zhong Liu; Bin-Kui Li; Hui-Lan Rao; Yi-Ji Liao; Xin-Yuan Guan; Yi-Xin Zeng; Dan Xie
Journal:  BMC Cancer       Date:  2009-12-22       Impact factor: 4.430

Review 2.  The three main stumbling blocks for anticancer T cells.

Authors:  Lukas Baitsch; Silvia A Fuertes-Marraco; Amandine Legat; Christiane Meyer; Daniel E Speiser
Journal:  Trends Immunol       Date:  2012-03-23       Impact factor: 16.687

Review 3.  Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.

Authors:  Asis Palazón; Julián Aragonés; Aizea Morales-Kastresana; Manuel Ortiz de Landázuri; Ignacio Melero
Journal:  Clin Cancer Res       Date:  2011-12-28       Impact factor: 12.531

4.  Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium.

Authors:  Asima Bhattacharyya; Ranajoy Chattopadhyay; Emily H Hall; Semret T Mebrahtu; Peter B Ernst; Sheila E Crowe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-09       Impact factor: 4.052

5.  Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.

Authors:  Hiroshi Yoshimura; Dipok Kumar Dhar; Hitoshi Kohno; Hirofumi Kubota; Toshiyuki Fujii; Shuhei Ueda; Shoichi Kinugasa; Mitsuo Tachibana; Naofumi Nagasue
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

6.  High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.

Authors:  Li-Ru He; Meng-Zhong Liu; Bin-Kui Li; Wei-Hua Jia; Ying Zhang; Yi-Ji Liao; Yang-Chao Chen; Lan-Jun Zhang; Xin-Yuan Guan; Yi-Xin Zeng; Hsiang-Fu Kung; Dan Xie
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

7.  T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response.

Authors:  Michail V Sitkovsky
Journal:  Trends Immunol       Date:  2009-02-07       Impact factor: 16.687

8.  HIF-1alpha and HIF-2alpha have divergent roles in colon cancer.

Authors:  Takaaki Imamura; Hirotoshi Kikuchi; Maria-Teresa Herraiz; Do-Youn Park; Yusuke Mizukami; Mari Mino-Kenduson; Maureen P Lynch; Bo R Rueda; Yair Benita; Ramnik J Xavier; Daniel C Chung
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

9.  Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.

Authors:  Yongshun Chen; You Lu; Changli Lu; Lei Zhang
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

10.  HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.

Authors:  P J Maxwell; R Gallagher; A Seaton; C Wilson; P Scullin; J Pettigrew; I J Stratford; K J Williams; P G Johnston; D J J Waugh
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 9.867

View more
  7 in total

1.  TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.

Authors:  P Guo; X Ma; W Zhao; W Huai; T Li; Y Qiu; Y Zhang; L Han
Journal:  Oncogene       Date:  2017-10-02       Impact factor: 9.867

Review 2.  Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review.

Authors:  Chunni Wang; Jingnan Wang; Zhaoli Chen; Yibo Gao; Jie He
Journal:  Chin J Cancer       Date:  2017-08-17

3.  Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling.

Authors:  Xiaoling Zhang; Yan Zhang; Yanan Jia; Tingting Qin; Cuicui Zhang; Yueya Li; Chengmou Huang; Zhujun Liu; Jing Wang; Kai Li
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

Review 4.  Exosome-related tumor microenvironment.

Authors:  Cheng Hu; Meijuan Chen; Rilei Jiang; Yuanyuan Guo; Mianhua Wu; Xu Zhang
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

5.  The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis.

Authors:  Susu Han; Tao Huang; Fenggang Hou; Liting Yao; Xiyu Wang; Xing Wu
Journal:  Ther Adv Med Oncol       Date:  2019-09-24       Impact factor: 8.168

Review 6.  Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.

Authors:  Jessica Waibl Polania; Emily C Lerner; Daniel S Wilkinson; Alexandra Hoyt-Miggelbrink; Peter E Fecci
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

7.  Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway.

Authors:  Hong Liu; Zhancheng Zhang; Shenli Zhou; Xianfang Liu; Guodong Li; Bing Song; Wei Xu
Journal:  Cancer Gene Ther       Date:  2021-07-19       Impact factor: 5.854

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.